La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Neurone dopaminergique »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neurone cholinergique < Neurone dopaminergique < Neurone gabaergique  Facettes :

List of bibliographic references indexed by Neurone dopaminergique

Number of relevant bibliographic references: 128.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000A98 (2014) C. P. Ford [États-Unis]THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION
000B15 (2014) G. Drui [France] ; S. Carnicella [France] ; C. Carcenac [France] ; M. Favier [France] ; A. Bertrand [France] ; S. Boulet [France] ; M. Savasta [France]Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
000B22 (2014) M. Morales [États-Unis] ; D. H. Root [États-Unis]GLUTAMATE NEURONS WITHIN THE MIDBRAIN DOPAMINE REGIONS
000B31 (2014) Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats
001D11 (2010) Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France]Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons
001D34 (2010) Jérémie Vitte [France] ; Sabine Traver [France] ; André Maues De Paula [France] ; Suzanne Lesage [France] ; Giorgio Rovelli [Suisse] ; Olga Corti [France] ; Charles Duyckaerts [France] ; Alexis Brice [France]Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease
001D45 (2010) Ouafa Arib [France] ; Pascal Rat [France] ; Robert Molimard [France] ; Abderrahman Chait [Maroc] ; Philippe Faure [France] ; Renaud De Beaurepaire [France]Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons
002130 (2009) Faustine Lelan [France] ; Philippe DamierLes neurones dopaminergiques greffés dans la maladie de parkinson sont-il à leur tour atteints par le processus dégénératif ?
002169 (2009) Serge Guerreiro [France] ; Aurélie Ponceau [France] ; Damien Toulorge [France] ; Elodie Martin [France] ; Daniel Alvarez-Fischer [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France]Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization
002182 (2009) Vincent Henry [France] ; Vincent Paille [France] ; Faustine Lelan [France] ; Philippe Brachet [France] ; Philippe Damier [France]Kinetics of Microglial Activation and Degeneration of Dopamine-Containing Neurons in a Rat Model of Parkinson Disease Induced by 6-Hydroxydopamine
002456 (2008) Pierre Cesaro [France]Neuroprotection et maladie de Parkinson
002473 (2008) Jacques Epelbaum [France]Foxa2, une nouvelle piste neuro-développementale pour le Parkinson
002494 (2008) Imane Nafia [France] ; Diane B. Re [France] ; Frédérique Masmejean [France] ; Christophe Melon [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; André Nieoullon [France] ; Laurence Had-Aissouni [France]Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction
002499 (2008) Daniel Hamack [Allemagne] ; Wassilios Meissner [France] ; Julia A. Jira [Allemagne] ; Christine Winter [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne]Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism
002510 (2008) Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France]Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
002512 (2008) Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France]Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse
002515 (2008) Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations
002797 (2007) Patrick P. Michel [France] ; Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Audrey Hild [France] ; Andreas Hartmann [France] ; Etienne C. Hirsch [France]Role of activity-dependent mechanisms in the control of dopaminergic neuron survival
002830 (2007) N. A. Do Thi [France] ; P. Saillour [France] ; L. Ferrero [France] ; T. Paunio [Finlande] ; J. Mallet [France]Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
002D51 (2005) Sophie Mourlevat [France] ; Thomas Debeir [France] ; Juan E. Ferrario [France] ; Jean Delbe [France] ; Daniele Caruelle [France] ; Olivier Lejeune [France] ; Christel Depienne [France] ; José Courty [France] ; Rita Raisman-Vozari [France] ; Merle Ruberg [France]Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons : Analysis of suppression-subtracted cDNA libraries and confirmation in vitro
002D87 (2005) I. J. Bohr [Royaume-Uni] ; M. A. Ray [Royaume-Uni] ; J. M. Mcintosh [États-Unis] ; S. Chalon [France] ; D. Guilloteau [France] ; I. G. Mckeith [Royaume-Uni] ; R. H. Perry [Royaume-Uni] ; F. Clementi [Italie] ; E. K. Perry [Royaume-Uni] ; J. A. Court [Royaume-Uni] ; M. A. Piggott [Royaume-Uni]Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases : An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Neurone dopaminergique" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Neurone dopaminergique" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Neurone dopaminergique
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024